Comparing Nifuroxazide Plus Lactulose With Lactulose Alone in the Treatment of Hepatic Encephalopathy
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Evaluating the efficacy and safety of the efficacy and safety of nifuroxazide in combination
with lactulose in comparison to lactulose alone in the treatment of hepatic encephalopathy in
patients with grade II-III hepatic encephalopathy